Prevalence, morphologic characteristic and predictors of organization of atrial auricle thrombi four weeks after anticoagulant preparation to scheduled electrical cardioversion of atrial fibrillation.

O. S. Kalashnykova

doi:10.26641/2307-0404.2013.3.18945

Автор(и)

O. S. Kalashnykova SE "Dnipropetrovsk medical academy Ministry of Health of Ukraine", Україна

DOI:

https://doi.org/10.26641/2307-0404.2013.3.18945

Ключові слова:

atrial fibrillation, atrial auricle thrombosis, thromboembolism complications, transesophageal echocardiography

Анотація

Goal: to study thrombosis prevalence and predictors of thrombi organization in atrial auricles in persistent non-valvular atrial fibrillation (NVAF) in patients undergoing transesophageal echocardiography (TEE) 4 weeks after oral anticoagulant therapy (OAC). Materials and methods: a total of 133 consecutive patients with NVAF, who underwent TЕE before electrical cardioversion (ECV) were included in the study. Results: The mean age of the participants was 60,3±0,9 years, 95 (71,4%) were men. The mean term of the last AF episode was 6,5±0,6 months. Duration of AF less than 1 year was in 47 (35,3%) patients, from 1 to 5 years – in у 61 (45,8%) patients, over 5 years – in 25 (18,8%) patients. 14 (10,5%) patients had underlying coronary artery disease (CAD), 84 (63,2%) patients had arterial hypertension, 31 (23,3%) had both CAD and arterial hypertension, 4 (3,0%) had cardiomyopathy, 80 (60,2%) were obese. NYHA I FC of heart failure (HF) was diagnozed in 8 (6,0%) patients, II FC – in 94 (70,7%) patients and III FC – in 31 (23,3%) patients. GFR > 90 ml/min/1,73m² was in 9 (6,8%) patients, in 74 (55,6%) it was decreased to 60-89 ml/min/1,73m², in 50 (37,6%) patients GFR was 30-59 ml/min/1,73m². In stratification of risk of thromboembolism complications (TEC) 91 (68,4%) fell into the high-risk group with the CHA2DS2-VASc score ≥ 2, 32 (24,1%) patients were in the moderate-risk group and 10 (7,5%) had CHA2DS2-VASc score 0. TEE was performed in all patients 4 weeks after effective OAC therapy. In 40 (37,6%) patients thrombi were detected in the left atrial auricle and in 26 (65,0%) patients they were organized. In 10 (7,5%) patients thrombis were detected in right atrial auricles and in 7 (70,0%) patients they were organized. In 63 (47,4%) patients thrombi were found in both atrial auricles and in 25 (39,7%) patients they were organized. Correlation was found between detection of non-organized thrombi, duration of AF less than 1 year and increase of total cholesterol. Thrombus organization was assotiated with AF duration more than 1 year. Conclusions: Clinical predictors linked with detection of non-organized atrial auricles thrombi in NVAF patients 4 weeks after OAC therapy are duration of AF less than 1 year, increase of total cholesterol, while thrombi organization is assotiated with AF duration more than 1 year.

Біографія автора

O. S. Kalashnykova, SE "Dnipropetrovsk medical academy Ministry of Health of Ukraine"

Department of Hospital Therapy N 2

Посилання

Маркеры риска тромбоэмболических ослож¬нений у пациентов с персистирующей фибрилляцией предсердий / М.Р. Икоркин, О.И. Жаринов, Н.П. Лев¬чук [и др.] // Укр. кардиол. журнал. – 2009. – № 6. – C. 32-40.

Оценка признаков тромбообразования у боль¬ных с длительным пароксизмом фибрилляции пред¬сердий методом чреспищеводной эхокардиографии / О.С. Сычев, А.О. Бородай, Е.Н. Романова [и др.] // Укр. кардиол. журнал. – 2010. – № 2. – С. 54-60.

Феномен спонтанного эхоконтрастирования в полости левого предсердия при постоянной форме мерцательной аритмии: что влияет на его выра¬жен¬ность? / А.Н. Сумин, Д.Н. Кинев, В.В. Агаджанян [и др.] // Кардиология. – 1999. – № 2. – С. 60-65.

Чреспищеводная эхокардиография в диагнос¬тике объемных образований сердца и паракардиаль¬ного пространства / И.Е. Рыкунов, В.А. Сандриков, Т.Д. Буравихина [и др.] // Кардиология. – 1996. – № 12. – С. 95-101.

Чреспищеводная эхокардиография в оценке состояния ушка левого предсердия у больных с па¬роксизмальной формой фибрилляции предсердий / М. Н. Алехин, С.Б. Ваниев, Е.Н. Майба [и др.] // Крем¬левская медицина. Клинич. вестник. – 2003. - № 3. – С. 15-17.

Advanced age, low left atrial appendage velocity, and factor V promoter sequence variation as predictors of left atrial thrombosis in patients with non-valvular atrial fibrillation / D.A. Zateyshchikov, A.N. Brovkin, D.A. Chis¬tia¬kov [et al.] // J. Thromb. Thrombolysis. – 2010. – Vol. 30, N 2. – P. 192-199.

Antithrombotic therapy in atrial fibrillation / G.W. Albers, J.E. Dalen, A. Laupacis [et al.] // Chest. – 2001. – Vol. 119, N 1. – P. 194-206.

Fatkin D. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic con¬trast and thromboembolic risk in vivo / D. Fatkin, R.P. Kel¬ly, M.P. Feneley // J. Am. Coll. Cardiol. – 1994. – Vol. 23. – P. 961-969.

Focused update of the ESC Guidelines for the management of atrial fibrillation / Eur. Heart. J. – 2012. – Vol. 33. – P. 2719-2747.

Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation / D. Scherr, D. Dalal, K. Chilukuri [et al.] // J. Cardiovasc. Electro¬phy¬siol. – 2009. – Vol. 20. – P. 379-384.

The use of anatomic M-mode echocardiography to determine the left atrial appendage functions in patients with sinus rhythm / A. Mahilmaran, P. G. Nayar, G. Su¬dar¬sana [et al.] // Echocardiography. – 2005. – Vol. 22, N 2. – P. 99-103.

Ikorkin MR, Zharinov OI, Levchuk NP. Markery riska tromboembolicheskikh oslozhneniy u patsientov s persistiruyushchey fibrillyatsiey predserdiy. Ukr. kardiol. zhurnal. 2009;6:32-40.

Sychev OS, Boroday AO, Romanova EN. Otsen¬ka priznakov tromboobrazovaniya u bol'nykh s dlitel'nym paroksizmom fibrillyatsii predserdiy metodom chres¬pishche¬vodnoy ekhokardiografii. Ukr. kardiol. zhurnal. 2010;2:54-60.

Sumin AN, Kinev DN, Agadzhanyan VV. Fe¬nomen spontannogo ekhokontrastirovaniya v polosti le¬vogo predserdiya pri postoyannoy forme mertsatel'noy aritmii: chto vliyaet na ego vyrazhennost'? Kardiologiya. 1999;2:60-65.

Rykunov IE, Sandrikov VA, Buravikhina TD. Chres¬pishchevodnaya ekhokardiografiya v diagnostike ob"emnykh obrazovaniy serdtsa i parakardial'nogo prost¬ranstva. Kardiologiya. 1996;12:95-101.

Alekhin MN, Vaniev SB, Mayba EN. Chres¬pishche¬vodnaya echocardiografiya v otsenke sostoyaniya ushka levogo predserdiya u bol'nykh s paroksizmal'noy formoy fibrillyatsii predserdiy. Kremlevskaya meditsina. Klinicheskiy vestnik. 2003;3:15-17.

Zateyshchikov DA, Brovkin AN, Chistiakov DA. Advanced age, low left atrial appendage velocity, and factor V promoter sequence variation as predictors of left atrial thrombosis in patients with non-valvular atrial fibrillation. J. Thromb. Thrombolysis. 2010;30(2):192-9.

Albers GW, Dalen JE, Laupacis A. Antithrom¬botic therapy in atrial fibrillation. Chest. 2001;119(1):194-206.

Fatkin D, Kelly RP, Feneley MP. Relations between left atrial appendage blood flow velocity, spon¬taneous echocardiographic contrast and thromboembolic risk in vivo. J. Am. Coll. Cardiol. 1994;23:961-9.

Focused update of the ESC Guidelines for the ma¬nagement of atrial fibrillation. Eur. Heart. J. 2012;33:2719-47.

Scherr D, Dalal D, Chilukuri K. Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation. J. Cardiovasc. Electrophysiol. 2009;20:379-84.

Mahilmaran A, Nayar PG, Sudarsana G. The use of anatomic M-mode echocardiography to determine the left atrial appendage functions in patients with sinus rhythm. Echocardiography. 2005;22(2):99-103.